pmid,title,journal,year,drug,disease
39695887,Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis.,"Advances in rheumatology (London, England)",2024,Tofacitinib,Arteriosclerosis Cardiovascular disease
36137735,Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.,Annals of the rheumatic diseases,2023,Tofacitinib,Arteriosclerosis Cardiovascular disease
34099646,Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.,Nature communications,2021,Tofacitinib,Arteriosclerosis Cardiovascular disease
29030660,Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.,Rheumatology international,2017,Tofacitinib,Arteriosclerosis Cardiovascular disease
28601639,Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.,Biochemical and biophysical research communications,2017,Tofacitinib,Arteriosclerosis Cardiovascular disease
17081232,"Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathy.",Transplant international : official journal of the European Society for Organ Transplantation,2006,Tofacitinib,Arteriosclerosis Cardiovascular disease
